Découvrez le nouveau Chem-Impex : là où l'innovation commence par une liaison.

Catalog Number:
38396
CAS Number:
80214-83-1
Roxithromycin
Purity:
≥ 95 % (HPLC)
Synonym(s):
Érythromycine 9-[O-(2-méthoxyéthoxy)méthyloxime]
Documents
$101.45 /5G
Taille
Request Bulk Quote
Informations sur le produit

Roxithromycin is a semi-synthetic macrolide antibiotic that is widely recognized for its effectiveness against a broad spectrum of bacterial infections. This compound is particularly valuable in the treatment of respiratory tract infections, skin infections, and sexually transmitted diseases. Its unique structure allows for enhanced tissue penetration and a longer half-life, making it a preferred choice in clinical settings. Roxithromycin is known for its ability to inhibit bacterial protein synthesis, which is crucial in combating resistant strains of bacteria.

In addition to its therapeutic applications, Roxithromycin has been utilized in various research settings to explore its potential in treating atypical pathogens and in combination therapies. Its favorable pharmacokinetic profile and lower incidence of gastrointestinal side effects compared to other antibiotics make it an attractive option for both healthcare providers and patients. Researchers and industry professionals can leverage Roxithromycin's unique properties to develop innovative treatment protocols and improve patient outcomes in infectious disease management.

Numéro CAS 
80214-83-1
Formule moléculaire
C41H76N2O15
Poids moléculaire 
837.06
Point de fusion 
120 °C
Rotation optique 
-93 à -96 ° (C=1, Acétone) (calculé sur substance anhydre)
Informations générales
Numéro CAS 
80214-83-1
Formule moléculaire
C41H76N2O15
Poids moléculaire 
837.06
Point de fusion 
120 °C
Rotation optique 
-93 à -96 ° (C=1, Acétone) (calculé sur substance anhydre)
Propriétés
Informations complémentaires sur la propriété à venir prochainement !
-
Sécurité et réglementation
Matières dangereuses
-
Antibiotique
-
Réglementé par la DEA
Non
Avertissements 
-
Applications

Roxithromycin is widely utilized in research focused on:

  • Antibiotic Therapy: This compound is primarily used to treat bacterial infections, particularly respiratory tract infections. Its effectiveness against a broad spectrum of bacteria makes it a preferred choice in clinical settings.
  • Pharmaceutical Development: Roxithromycin serves as a model compound in the development of new macrolide antibiotics, allowing researchers to study structure-activity relationships and enhance drug efficacy.
  • Veterinary Medicine: The compound is also applied in veterinary practices to treat infections in animals, ensuring their health and well-being, which is crucial for livestock and pets alike.
  • Research on Drug Resistance: It is used in studies investigating antibiotic resistance mechanisms, helping scientists understand how bacteria adapt and develop resistance, which is vital for developing new treatments.
  • Formulation Science: Roxithromycin is explored in various drug formulations, including extended-release and combination therapies, enhancing patient compliance and therapeutic outcomes.

Citations